“…Additionally, TRPM8-immunoreactive staining has been observed in the urothelium and in nerve fibers distributed throughout the suburothelium, and a marked increase in the number of fine-caliber nerve fibers immunoreactive for TRPM8 was found in patients with BPS compared with controls (P < 0.05) (Mukerji et al, 2006). Furthermore, TRPM8 antagonists lower body temperature in rats, and might be used to treat cold hypersensitivity and hyperalgesia in several neuropathic conditions, including complex regional pain syndrome and trigeminal neuralgia, peripheral nerve injury, and chemotherapy-induced neuropathy (Almeida et al, 2012;Gavva et al, 2012;Patel et al, 2014;Winchester et al, 2014). Moreover, TRPM8 has higher expression in prostate cancer tissue than in normal prostate tissue, and has also been detected in tumors of the breast, colon, lung, skin, and pancreas (Tsavaler et al, 2001;Yee et al, 2010;Okamoto et al, 2012).…”